Skip to main content
. 2001 Aug;75(16):7375–7383. doi: 10.1128/JVI.75.16.7375-7383.2001

TABLE 1.

Constructs transfected to generate VLPsa

Plasmid Amt (μg) of construct used
WT A21/B/NEP delNES/NEP −NEP
pCAGGS-B/Yamagata/73/PB1 1 1 1 1
pCAGGS-B/Yamagata/73/PB2 1 1 1 1
pCAGGS-B/Yamagata/73/PA 1 1 1 1
pCAGGS-B/Lee/40/HA 1 1 1 1
pCAGGS-B/Lee/73/NP 1 1 1 1
pCAGGS-B/Yamagata/73/NANB 1 1 1 1
pCAGGS-B/Yamagata/73/M1 1 1 1 1
pCAGGS-B/Yamagata/73/BM2 1 1 1 1
pCAGGS-B/Yamagata/73/NS1 1 1 1 1
pCAGGS-B/Lee/40/NEP 1 0 0 0
pCAGGS-A21/B/NEP 0 1 0 0
pCAGGS-B/delNES/NEP 0 0 1 0
pPOLI-B/Lee/NSCAT 1 1 1 1
a

Eukaryotic expression plasmids were constructed for the influenza B virus gene products and used to generate VLPs after transfection into 293T cells. WT, the plasmids corresponding to the complete set of plasmids representing the entire set of influenza B virus gene products, including a viral RNA-like CAT gene. A21/B/NEP replaces the wild-type NEP with the construct pCAGGS-A21/B/NEP. In the column labeled delNES/NEP, wild-type NEP is replaced with a mutant version of NEP lacking the first 20 aa. −NEP, the complete set without the plasmid encoding the NEP protein from influenza B virus. In all cases 1 μg per plasmid was transfected for a total of 10 or 11 μg (−NEP or others, respectively). Supernatants of transfected cells showed HA titers of log 25 in repeated experiments.